NCT07112053 2026-03-09
A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
University of Washington
Phase 2 Recruiting
Clinical Trials
4 trialsNCT05659797 2026-02-27
FES BPET-DBT in Newly Diagnosed Breast Cancer
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Recruiting
NCT06260033 2025-10-06
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
City of Hope Medical Center
Phase 2 Recruiting
NCT05916196 2025-05-08
[18F]FES PET/.CT in Uterine Cancer
Abramson Cancer Center at Penn Medicine
Phase 2 Recruiting